ES2118831T3 - Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico. - Google Patents

Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico.

Info

Publication number
ES2118831T3
ES2118831T3 ES92921289T ES92921289T ES2118831T3 ES 2118831 T3 ES2118831 T3 ES 2118831T3 ES 92921289 T ES92921289 T ES 92921289T ES 92921289 T ES92921289 T ES 92921289T ES 2118831 T3 ES2118831 T3 ES 2118831T3
Authority
ES
Spain
Prior art keywords
preparations containing
hemotopoyetic
lobaplatin
stimulation
carboplatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921289T
Other languages
English (en)
Inventor
Regina Reszka
Iduna Fichtner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Application granted granted Critical
Publication of ES2118831T3 publication Critical patent/ES2118831T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL EMPLEO DE COMPUESTOS DE METAL DE TRANSICION SOLUBLES EN AGUA O EN LIPIDOS EN MESOFASES LIOTROFAS PARA LA ESTIMULACION DEL SISTEMA HEMATOPOYETICO Y/O PARA TERAPIA ANTITUMORAL, ASI COMO PREPARACIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y SU PREPARACION. DE ESTE MODO, POR EJEMPLO, FUE OBTENIDO CON CARBOPLATINO LIPOSOMAL, UN AUMENTO POR ENCIMA DE LA MEDIA DE LAS CANTIDADES DE LEUCOCITOS.
ES92921289T 1991-10-11 1992-10-09 Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico. Expired - Lifetime ES2118831T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134158A DE4134158C2 (de) 1991-10-11 1991-10-11 Verwendung von Carboplatin in lyotrophen Mesophasen zur Überwindung einer durch Zytostatika ausgelösten Leukopenie

Publications (1)

Publication Number Publication Date
ES2118831T3 true ES2118831T3 (es) 1998-10-01

Family

ID=6442748

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921289T Expired - Lifetime ES2118831T3 (es) 1991-10-11 1992-10-09 Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico.

Country Status (9)

Country Link
EP (1) EP0611303B1 (es)
JP (1) JP3627240B2 (es)
AT (1) ATE166576T1 (es)
AU (1) AU2755192A (es)
DE (2) DE4134158C2 (es)
DK (1) DK0611303T3 (es)
ES (1) ES2118831T3 (es)
GR (1) GR3027576T3 (es)
WO (1) WO1993006824A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19505960A1 (de) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Konjugat zur individuellen Dosierung von Arzneimitteln
DE60237162D1 (de) * 2001-10-03 2010-09-09 Celator Pharmaceuticals Inc Liposomenladung mit metallionen
KR100594353B1 (ko) * 2002-05-28 2006-07-03 주식회사 엠디바이오알파 신규한 인삼잎 및 줄기 다당체, 그 제조방법 및 그를활성성분으로 함유하는 항암제 및 항암보조제 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134709A1 (de) * 1981-09-02 1983-03-10 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Antineoplastisch wirkende titanverbindung und diese enthaltende arzneimittel
HU190579B (en) * 1984-07-18 1986-09-29 Nitrokemia Ipartelepek,Hu Plant growth regulating compositions comprising etherified hydroxy-alkyl-phosphonic acid-derivatives as active substance
DE3572981D1 (en) * 1984-07-24 1989-10-19 Asta Pharma Ag Ruthenium compounds having a tumor inhibiting activity
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
WO1991002531A1 (en) * 1989-08-17 1991-03-07 Peter Maccallum Cancer Institute Method for the modulation of haemopoiesis in a mammal

Also Published As

Publication number Publication date
DE4134158A1 (de) 1993-04-15
DE59209351D1 (de) 1998-07-02
JPH08508237A (ja) 1996-09-03
JP3627240B2 (ja) 2005-03-09
DE4134158C2 (de) 1997-02-13
DK0611303T3 (da) 1999-03-22
WO1993006824A1 (de) 1993-04-15
AU2755192A (en) 1993-05-03
GR3027576T3 (en) 1998-11-30
EP0611303A1 (de) 1994-08-24
ATE166576T1 (de) 1998-06-15
EP0611303B1 (de) 1998-05-27

Similar Documents

Publication Publication Date Title
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
ES2130651T3 (es) Lipidos del tipo ceramida modificados con polietilenglicol y liposomas.
AR004445A1 (es) Una composicion inmunogenica, una dosis unitaria, un metodo para producir la composicion, un kit para producir la composicion, una poblacion de celulas,uso de dicha poblacion celular y una preparacion combinada
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
ATE234274T1 (de) Derivate des adamantan
DK0668769T3 (da) Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
ES8502405A1 (es) Un metodo para producir una emulsion acuosa de perfluorocarburo
ES2081366T3 (es) Uso de la il-7 en la preparacion de medicaciones para estimular la produccion de plaquetas.
ES2040208T3 (es) Pirazolinas insecticidas.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
ATE188873T1 (de) Tris-platin-komplexe
ES8703844A1 (es) Un procedimiento para preparar derivados de bencimidazol
ES2118831T3 (es) Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico.
ES2071995T3 (es) Composicion para la activacion de macrofagia.
RU94030808A (ru) Применение фосфокриатина или фосфоенолпировиноградной кислоты для лечения опухолей и фармацевтические препараты, обладающие противоопухолевой активностью
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
IT1199972B (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
ES2012547A6 (es) Procedimiento para preparar una composicion farmaceutica que contiene metaloporfirinas.
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
IT8220583A0 (it) Complessi organometallici di n-cicloesil-piperazino-acetammidi o propionammidi, loro preparazione e impiego come farmaci antiulcera-antisecretivi-tamponanti .

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 611303

Country of ref document: ES